- Abstract:
-
PURPOSE: The development of tumor-specific markers to select targeted therapies and to assess clinical outcome remains a significant area of unmet need. We evaluated the association of baseline circulating tumor cell (CTC) number with clinical characteristics and survival in patients with castrate metastatic disease considered for different hormonal and cytotoxic therapies. EXPERIMENTAL DESIGN: CTC were isolated by immunomagnetic capture from 7.5-mL samples of blood from 120 patients with pr...
Expand abstract - Journal:
- Clinical cancer research : an official journal of the American Association for Cancer Research
- Volume:
- 13
- Issue:
- 23
- Pages:
- 7053-7058
- Publication date:
- 2007-12-05
- DOI:
- EISSN:
-
1557-3265
- ISSN:
-
1078-0432
- URN:
-
uuid:f1050e02-827a-4c3b-ac23-d6d1252702b4
- Source identifiers:
-
365940
- Local pid:
- pubs:365940
- Language:
- English
- Keywords:
- Copyright date:
- 2007
Journal article
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record